4//SEC Filing
Daly Richard J 4
Accession 0001161697-25-000025
CIK 0001369568other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:00 PM ET
Size
9.2 KB
Accession
0001161697-25-000025
Insider Transaction Report
Form 4
Daly Richard J
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-01-02−42,105→ 2,238,753 total→ Common Stock (42,105 underlying) - Exercise/Conversion
Common Stock, par value $0.001 per share
2025-01-02+42,105→ 277,938 total - Tax Payment
Common Stock, par value $0.001 per share
2025-01-02−10,600→ 267,338 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
- [F3]Derivative securities vest in equal tranches, 1/5th each on January 1, 2025, 2026, 2027, 2028 and 2029.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on January 2, 2025.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001635393
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:00 PM ET
- Size
- 9.2 KB